Funding for this research was provided by:
National Natural Science Foundation of China (82173134)
Received: 15 June 2022
Revised: 4 July 2022
Accepted: 5 July 2022
First Online: 2 August 2022
: The authors declare no conflict of interest. Hongming Miao is the editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling.